| 注册
首页|期刊导航|哈尔滨医药|Bevacizumab药物的毒性评估与安全性实验研究

Bevacizumab药物的毒性评估与安全性实验研究

娄人介

哈尔滨医药2024,Vol.44Issue(3):8-10,3.
哈尔滨医药2024,Vol.44Issue(3):8-10,3.DOI:10.3969/j.issn.1001-8131.2024.03.003

Bevacizumab药物的毒性评估与安全性实验研究

Toxicity Assessment and Safety Experimental Study of the Drug Bevacizumab

娄人介1

作者信息

  • 1. 美国加州大学戴维斯分校,文理学院药物化学系,加州 戴维斯 95616
  • 折叠

摘要

Abstract

The article discusses the importance of drug toxicity assessment and how to reduce drug toxicity through modifications of chemical structures.It details an experiment on the toxicity assessment of an anticancer drug(Bevacizumab).The experiment used both animal models and cell culture methods to comprehensively evaluate the safety of Bevacizumab.The results showed that Bevacizumab exhibited certain toxicity to rats and human liver cell culture systems at high doses or concentrations.It is recommended that further drug development should involve optimization of chemical structures to reduce potential toxicity risks.This research not only provides important safety data for further drug development but also offers a comprehensive experimental model for drug toxicity assessment.

关键词

药物/毒性/评估/安全性

Key words

Drugs/Toxicity/Assessment/Safety

分类

医药卫生

引用本文复制引用

娄人介..Bevacizumab药物的毒性评估与安全性实验研究[J].哈尔滨医药,2024,44(3):8-10,3.

哈尔滨医药

1001-8131

访问量0
|
下载量0
段落导航相关论文